This document provides information about the drug triazolam, including its mechanism of action, indications, contraindications, side effects, nursing considerations, and prescribing information. Specifically, it notes that triazolam is a benzodiazepine sedative/hypnotic that acts in the central nervous system to produce generalized depression. It is indicated for short-term management of insomnia but has contraindications in pregnancy, breastfeeding, hepatic or renal impairment, and hypersensitivity. Common side effects involve the central nervous system like abnormal thinking and dizziness. Nursing considerations before administration include assessing mental status in elderly patients and avoiding look-alike drug names.
This document provides information about the drug triazolam, including its mechanism of action, indications, contraindications, side effects, nursing considerations, and prescribing information. Specifically, it notes that triazolam is a benzodiazepine sedative/hypnotic that acts in the central nervous system to produce generalized depression. It is indicated for short-term management of insomnia but has contraindications in pregnancy, breastfeeding, hepatic or renal impairment, and hypersensitivity. Common side effects involve the central nervous system like abnormal thinking and dizziness. Nursing considerations before administration include assessing mental status in elderly patients and avoiding look-alike drug names.
This document provides information about the drug triazolam, including its mechanism of action, indications, contraindications, side effects, nursing considerations, and prescribing information. Specifically, it notes that triazolam is a benzodiazepine sedative/hypnotic that acts in the central nervous system to produce generalized depression. It is indicated for short-term management of insomnia but has contraindications in pregnancy, breastfeeding, hepatic or renal impairment, and hypersensitivity. Common side effects involve the central nervous system like abnormal thinking and dizziness. Nursing considerations before administration include assessing mental status in elderly patients and avoiding look-alike drug names.
This document provides information about the drug triazolam, including its mechanism of action, indications, contraindications, side effects, nursing considerations, and prescribing information. Specifically, it notes that triazolam is a benzodiazepine sedative/hypnotic that acts in the central nervous system to produce generalized depression. It is indicated for short-term management of insomnia but has contraindications in pregnancy, breastfeeding, hepatic or renal impairment, and hypersensitivity. Common side effects involve the central nervous system like abnormal thinking and dizziness. Nursing considerations before administration include assessing mental status in elderly patients and avoiding look-alike drug names.
Download as DOCX, PDF, TXT or read online from Scribd
Download as docx, pdf, or txt
You are on page 1of 4
DRUG THERAPEUTIC RECORD
Name Reason for Admission
Age Sex Female Medical Impression
DRUG DRUG CLASS MECHANISM OF INDICATIONS CONTRAINDICATIONS SIDE EFFECTS/ADVERSE NURSING
NAME ACTION REACTIONS CONSIDERATIONS Acts at many levels in Generic: Therapeutic: the CNS, producing Patient’s Contraindicated in: Side Effects: Before: triazolam sedative/hypnotics generalized Indications: -Assess mental -Contraindicated in CNS: abnormal thinking, depression. Effects Short-term status before pregnant patients and behavior changes, dizziness, may be mediated by management starting therapy those hypersensitive to excessive sedation, gamma-aminobutyric of insomnia. and reduce doses in benzodiazepines. hangover, headache, Brand: Pharmacologic: acid (GABA), an elderly patients; Apo-Triazo, benzodiazepines inhibitory anterograde amnesia, these patients may General: Use cautiously in. confusion, hallucinations, Gen- neurotransmitter. be more sensitive Triazolam, sleep driving, lethargy, to drug’s adverse -Breast-feeding mental depression, Halcion, Therapeutic Effects: CNS effects. women. paradoxical excitation. Novo- Reliefs Insomnia Triolam, Nu- EENT: blurred vision. GI: -Look alike–sound -Patients with impaired constipation, diarrhea, Triazo alike: Don’t confuse hepatic or renal nausea, vomiting. Derm: Halcion with Haldol function, chronic rashes. Misc: physical or halcinonide. pulmonary dependence, psychologic insufficiency, sleep dependence, tolerance During: apnea, mental Complete -Anaphylaxis and depression, suicidal Adverse Reactions: Prescription: angioedema may tendencies, or history CNS: complex sleep-related occur as early as of drug abuse behaviours, the first dose; drowsiness, amnesia, ataxia, monitor the depression, patient closely. dizziness, headache, lack of coordination, Pregnancy Category: -Take precautions mental confusion, Date of Rx: to prevent hoarding nervousness, physical or overdosing by or psychological patients who are dependence, rebound depressed, suicidal, insomnia. or drug-dependent GI: nausea, vomiting. or who have history Other: anaphylaxis, of drug abuse. angioedema Overdose S&S: Somnolence, After: impaired coordination, - Monitor CBC, slurred speech, confusion, chemistry, and coma, decreased reflexes, urinalysis. hypotension, seizures, respiratory depression, -Monitor minor apnea changes in EEG patterns (usually Low-voltage fast activity) may occur during and after therapy report to the physician immediately
-Warn patient that
drug may cause allergic reactions, facial swelling, and complex sleep- related behaviors, such as driving, eating, and making phone calls while asleep.
-Advise patient to report these adverse effects.
-Warn patient not
to take more than prescribed amount; overdose can occur at total daily dose of 2 mg (or four times highest recommended amount).
-Tell patient to avoid alcohol use while taking drug.
-Warn patient not
to stop drug abruptly after taking for 2 weeks or longer. - Caution patient to avoid performing activities that require mental alertness or physical coordination.
-Inform patient that
drug doesn’t tend to cause morning drowsiness.
- Tell patient that
rebound insomnia may occur for 1 or 2 nights after stopping therapy. Reference: